Brief: Lumiradx Reports Third Quarter 2022 Results
Nov 9 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX REPORTS THIRD QUARTER 2022 RESULTS
* Q3 2022 REVENUE OF $42.2 MILLION COMPARED TO Q2 2022
REVENUE OF
$44.7 MILLION AND Q3 2021 REVENUE OF $109.1 MILLION
* GLOBAL RESTRUCTURING PLAN ON TRACK WITH COST-SAVING
INITIATIVES
IMPLEMENTED OF $18 MILLION PER QUARTER
* QTRLY LOSS PER SHARE $0.47
Source text for Eikon: ID:nGNX3DLhb4
Further company coverage: LMDX.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing